Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sotalol: Current Status and Expanding Indications.

Singh1

  • 1UCLA School of Medicine, Veterans Affairs Medical Center of West Los Angeles, Los Angeles, California, USA

Journal of Cardiovascular Pharmacology and Therapeutics
|February 23, 2000
PubMed
Summary

Sotalol, a potent antiarrhythmic drug, effectively controls supraventricular and ventricular arrhythmias by combining Class III and beta-blocking actions. It is particularly valuable for managing life-threatening ventricular tachycardia and fibrillation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Studies on the Electrochemical Characterization of Cellulose Acetate and Dowex-50 Membranes for Uni-Univalent Electrolytes in Aqueous Solutions.

Journal of colloid and interface science·1999
Same author

Evolution of a mammalian promoter through changes in patterns of transcription factor binding

Journal of molecular evolution·1999
Same author

Thermodynamics of kappa-Carrageenan-Amphiphilic Drug Interaction as Influenced by Specific Counterions and Temperature: A Microcalorimetric and Viscometric Study.

Journal of colloid and interface science·1998
Same author

The Synthesis of Phycopsisenone, a New Phenolic Secondary Metabolite from the Sponge Phycopsis sp.

Journal of natural products·1998
Same author

Rotational Analysis of the 0-0 Band of the a3Pi-X1Sigma+ Transition of AlCl

Journal of molecular spectroscopy·1998
Same author

Liesegang Ring Type Structures and Bifurcation in Solid-Vapor and Liquid Phase Reactions between Cobalt Nitrate and Ammonium Hydroxide

Journal of colloid and interface science·1997

Area of Science:

  • Cardiology
  • Pharmacology
  • Electrophysiology

Background:

  • Antiarrhythmic drug therapy is evolving due to invasive procedures like catheter ablation and implantable devices.
  • Conventional sodium channel blockers show limitations, including ineffectiveness and proarrhythmic potential.
  • Focus is shifting to drugs prolonging repolarization and reducing sympathetic stimulation, with sotalol and amiodarone as key examples.

Purpose of the Study:

  • To review the efficacy of sotalol in managing supraventricular and ventricular tachyarrhythmias.
  • To highlight sotalol's unique combination of Class III antiarrhythmic and non-selective beta-blocking properties.
  • To discuss sotalol's pharmacokinetic profile and dosing considerations.

Main Methods:

  • Review of existing literature on sotalol's use in tachyarrhythmia management.

Related Experiment Videos

  • Analysis of sotalol's pharmacokinetic properties, including elimination half-life and renal excretion.
  • Evaluation of sotalol's clinical effectiveness in preventing inducible and spontaneous arrhythmias.

    • Main Results:

    • Sotalol demonstrates broad-spectrum antiarrhythmic actions against both supraventricular and ventricular arrhythmias.
    • It effectively prevents inducible ventricular tachycardia (VT) and ventricular fibrillation (VF) in a significant percentage of patients.
    • Sotalol is associated with suppression of spontaneously occurring arrhythmias documented on Holter monitoring.

    Conclusions:

    • Sotalol plays a major role in managing VT/VF, especially with implantable cardioverter-defibrillators, by lowering the defibrillation threshold.
    • It is superior to Class I antiarrhythmic agents for VT/VF and in cardiac arrest survivors.
    • Sotalol is a key antifibrillatory agent for life-threatening ventricular arrhythmias and shows potential in managing atrial fibrillation and flutter.